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In 1996–98, when this author was an assistant professor in Chennai, he had published his viewpoint in Indian Journal of Practical Pediatrics arguing against the existence of the now 
well-accepted condition hypernatremic dehydration due to breast 
milk insufficiency [1]. Not only reference weight loss has been 
suggested for early identification of hypernatremic dehydration 
but also strong protagonists of breastmilk have suggested the use 
of occasional bottle feeding on such rare occasions in the interest 
of the baby [2,3].
Wang et al. have recently reported the serial values of sialic acid 
and iron content of breast milk at different stages of lactation [4]. 
This article again raises an important practical question - how 
closely could infant milk formulas mimic the nature’s gift of 
human milk. This article provided the impetus to academically 
(acamedically!) analyze this question in the current era with special 
reference to India and other economically poorer economies.
The benefits of human milk and its supremacy over the infant 
formulas have traditionally been outlined as immunological, 
economical, and nutritional factors [5]. The immunological factors 
are the ones which are responsible for designating human milk as 
“living biological fluid [5].” These immunological factors include 
secretory IgA, interleukins, interferons, and cellular factors, 
and complement factors. The purported beneficial effects of 
human milk in protecting against respiratory and gastrointestinal 
infections presumably result from these immunological factors. 
The increased risk of infections is to a major extent muffled in 
the developed world by the superior hygiene that results from the 
ease of availability of portable drinking water.
Human milk is readily available for feeding the infant and 
results in considerable savings from the economic cost that results 
from purchasing formula milk together with the added cost of 
treating infections and malnutrition resulting from the unhygienic 
preparation of formula feeds with improper over-dilution. In 
an earlier study from Northern India, it has been reported that 
the cost of formula feeding in Indian setting is 3 times the per 
capita income [6]. Thus, the economic benefits of breastfeeding 
overwhelmingly tilt the balance in its favor against a major 
opposing force that is the risk of transmitting HIV in economically 
underprivileged population. This led to the dichotomy of World 
Health Organization (WHO) recommendation for feeding HIV 
positive infants [7].
Human milk oligosaccharides (HMO) are the second 
most abundant glycans next only to lactose present in human 
milk. They are not digestible in the infant’s gut, and so their 
component sugars cannot serve a calorific purpose as do the other 
macronutrients [8,9]. On the other hand, they play a major role 
in preventing gut infections by enteropathogens such as cholera, 
rotavirus, and Escherichia coli by a decoy mechanism (mimicking 
intestinal receptors for these enteropathogens) [8]. Sialic acid in 
its form as N acetyl moiety is an important component of HMO. 
Human milk contains the appropriate form of sialic acid as the 
N acetylneuraminic acid whereas the bovine milk contains N 
glycolylsialic acid which might be biologically harmful.
Breastfed preterm infants have an IQ advantage of 
7.5 points over their bottle-fed counterparts at ages 7.5–8 years 
while term infants have a modest but questionable increase of 
3 points [10,11]. Brain maturation and myelination in early infancy 
are putatively facilitated by human milk and its components 
(the nutritional factor) apart from the unquantifiable emotional 
bonding factor. The role of omega3 (docosahexaenoic acid) and 
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omega 6 (arachidonic acid) in conferring this IQ advantage has 
been copied by infant formulas [12]. The relative contribution 
by sialylated HMO in conferring this IQ advantage is not clearly 
deciphered at this moment [9].
Human milk has special benefits for premature infants so 
much so that it is hailed as “baby specific” by the protagonists 
because of the differential composition of preterm milk protein 
and immunological factors versus the term human milk. 
However, the inadequacies of preterm milk in terms of volume 
availability, calorie, and micronutrient composition such as 
iron, calcium, and Vitamin D have also been well known. The 
need for adequate milk volume for preterm babies during the 
initial colostrum phase (hypoglycemic risk phase) mandates 
the use of infant formula/banked human milk for bridging the 
volume gap. Tolerance had been an important issue with earlier 
preterm milk along with the risk of necrotizing enterocolitis, 
but with the addition of prebiotics and probiotics, this risk is 
proven to be mollified to a great extent [13-15]. In a study by 
Modi et al., on the supplementation of galactooligosaccharides 
and fructooligosaccharides in the ratio of 9:1 (prebiotic) to 
preterm infant formulas in babies <32 weeks, the prebiotic-
supplemented group had better enteral tolerance leading to a 
faster establishment of full enteral feeds (150 mL/kg/day) [13]. 
Only 8% of infants in that study was exclusively breastfed, and 
only 15% exclusively formula feed meaning that about 75% of 
preterm babies need formula feeds in addition to human milk 
(both groups together) [13].
In a cohort study on routine supplementation of all neonates 
weighing between 1000 and 1999 g at birth with probiotic 
(Saccharomyces boulardii), the authors found that the incidence 
of severe sepsis and necrotizing enterocolitis Stage 2 and 
above and all-cause mortality was significantly lowered in 
the supplemented group. In this study, over 90% of the babies 
were exclusively fed on maternal preterm milk in both the 
control and supplemented groups. These results reiterate that 
ensuring exclusive breastfeeding alone may not be successful in 
reducing severe Gram-negative sepsis in Indian units [14]. In a 
WHO commissioned systemic review, Kramer et al. conclude 
that exclusive breastfeeding does not significantly reduce the 
rate of atopic eczema, respiratory infection, otitis media, and 
hospitalization for respiratory and gastrointestinal infections [16].
The immune benefits of human milk have been studied before, 
but the putative mechanisms for these benefits have been evaluated 
only in a few recent studies. In an earlier randomized controlled 
study from Delhi, Narayanan et al. had reported significantly 
reduced hospital-acquired infection rates in the human milk-fed 
group, and this was despite a higher “contamination” rate with the 
expressed human milk than the formula milk [17]. A subsequent 
study found that this so thought contamination was indeed by 
the innate flora of the lactation that results from translocation of 
maternal bacteria from the mothers gut and plays an important 
role in educating the immature neonatal immune cells to tolerance 
of beneficial commensals in the intestine [18]. Immunological 
benefits to young infants that accrue from human milk have 
previously been ascribed to a major extent to the passive transfer 
of maternal immunoglobulins (secretory IgA in particular).
Recent experiments in murine pups suggest that the protective 
cellular mechanisms may also be equally if not more relevant 
in that maternal human milk derived CD8 cytotoxic T cells 
preferentially home in to the payers patches of the pups and elicit 
protective immune responses to compensate for the defective 
immune response of the native T lymphocytes of the infant [19]. 
The Promotion of Breastfeeding Intervention Trial (PROBIT) is 
the largest cluster randomized trial conducted in the Republic of 
Belarus with 17,046 mother-infant dyads participating with long-
term follow-up [20]. Significant benefits seen in the breastfeeding 
group were a reduction in the diarrhea rate and atopic eczema 
at 12 months follow-up and an improvement in cognitive ability 
at 6.5 years follow-up [20,21]. The 11.5 years follow-up data of 
PROBIT are currently under review for publication [21].
Coming to the real-life scenario on the prevalence of 
breastfeeding as well as exclusive breastfeeding in different 
countries, the available data are not that encouraging! The 
all out efforts to promote exclusive breastfeeding in India by 
the Breast milk promotion network of India (BPNI) and other 
national associations have not yielded the desired results and 
the proportion of mothers exclusively breastfeeding their infants 
<6 months of age in 2 well- conducted National Family Health 
Surveys (NFHS) separated over a 13 and 23 years’ time frame 
bears testimony to this 46.3% in NFHS 1 1992–1993, 48.6% in the 
NHFS 3 2005–2006, and 52.1% in NHFS 2016 [22]. This figure is 
a cumulative sum of all mothers exclusively breastfeeding at any 
point within 6 months of infant age which means that if a single 
valid point of 6 months of infant age is taken, then the figure will 
be only of the order of 20% as reported in a previous study [6]. 
Obviously, the data in economically developed countries can 
be no better with reported percentage of mothers exclusively 
breastfeeding at 6 months being 2% in the United Kingdom and 
18% in the United States [23].
Despite the 25 years existence of stringent infant milk 
substitutes (IMS) feeding bottles, and infant foods (regulation 
of production, supply, and distribution) act enacted way back in 
1992 (IMS Act) and an exclusive association (BPNI) that is in 
existence from the same year the exclusive breastfeeding rate in 
the country has seen only a notional increase of 5.8%. What could 
be the underlying reasons?
1. Majority of the Indian mothers are still homemakers as 
evidenced by the percentage of female workers out of the 
total workforce in rural India (25%) and urban India (15%). 
Hence, the issue of availability of adequate maternity leave 
is not the issue in the vast majority of the mothers [24].
2. Health education and spreading awareness about benefits of 
breastfeeding are the legal and accepted way of practice in 
India with all health associations endorsing breastfeeding. 
Institutional deliveries in India have increased from 35% in 2006 
to 79% in 2014 [25]. That means the majority of mother-infant 
dyads are accessing services of physicians for delivery and 
subsequent follow-up visits including immunizations.
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3. Hence, the obvious inference is that health-care professionals 
are not able to convince, support, and ensure that the exclusive 
breastfeeding rates improve significantly and at a faster 
pace. This may be due to the fact that influences outside our 
purview such as domestic elders’ views (grandmothers, etc.), 
peer group pressures and social media messages (people trust 
social media messages more easily than the physicians), and 
personal conveniences often overwhelm the professional 
recommendations.
4. The increased purchasing power of the Indian households; 
especially, in urban areas may also be a contributing factor.
5. The modern-day formula milk manufacturers also proclaim 
that the incremental benefits of human milk are not 
significant and by these claims, they have been able to 
provide reassurance and comfort to lactating mothers facing 
inadequate supply and a hungry, irritable baby!
To be on the positive side, it is entirely possible that the 
exclusive breastfeeding rates have not declined in Indian 
population despite all the opposing market forces due to the 
untiring efforts of professionals and lawmakers in India. Hence, 
while we can redouble efforts to promote exclusive breastfeeding, 
the vibrant supply of infant formulas exists, and we have to accept 
this ground reality!
The denouement: For formula feeding: Why should we 
(attempt to) conquer nature?
•	 The	volume	of	human	milk	available	during	 the	colostrum	
phase (15–20 mL in the first 24 h) is often inadequate to 
achieve euglycemia in babies at risk of hypoglycemia [26].
•	 Human	milk-fed	infants	have	a	six-fold	increased	occurrence	of	
bilirubin levels >15 mg in the neonatal period than their formula-
fed counterparts. Lactation failure is the underlying factor in the 
majority of these babies who suffer from dehydration and weight 
loss. On the other hand, there are certain gene polymorphism 
variants of uridine diphosphoglucuronic transferase 1 enzyme, 
that when coupled with human milk feeding, could result in a 
massive 22–88-fold increase in significant hyperbilirubinemia 
>20 mg [27]. All cases of kernicterus over the previous 3 
decades that happened in the USA were all in breastfed 
infants [26]. Hence, guidelines from academic associations 
do mention exclusive human milk feeding as a significant 
independent risk factor for hyperbilirubinemia [27].
•	 There	are	many	situations	where	a	substitute	for	human	milk	
is a necessity such as parental choice and maternal infections 
such as HIV, working women, destitute babies, infants with 
metabolic errors, and severe atopy.
•	 The	advanced	infant	formulas	of	the	modern	age	are	claiming	
to have copied all the beneficial constituents of the human 
milk, and only the immunological factors cannot be provided 
for in the formula milk as available in human milk.
•	 However,	in	developing	countries	like	rural	India,	considering	
the economic cost savings offered by exclusive breastfeeding 
and lack of universal access to potable water, formula milk 
feeding can be accepted as an alternative only when the 
parents choose to give formula milk instead of breast milk.
For breastfeeding: Why nature should not be conquered?
•	 Even	over	a	span	of	3000	years	in	spite	of	our	best	efforts	to	
understand the human body - its physiology and functions, 
many things remain as elusive to decipher as before. Many 
of our misguided experiments in modern medicine have 
backfired. The infant formulas per se have been designed 
to mimic the human milk with respect to its nutrient 
and nonnutrient factors so much to say that nature is the 
benchmark gold standard for technology. It may quite rightly 
be said that we cannot make cow produce human milk using 
genetic engineering.
•	 In	 developing	 economies	 like	 India,	 the	 cost	 economics	
of human milk feeding coupled with the sinister of bottle 
feeding with infant formulas, especially the hygiene part of 
it, make breastfeeding promotion the norm as the majority of 
Indians still lives in its villages.
•	 The	author	has	observed	that	in	a	rural	health	medical	facility	
of a medical college, exclusive breastfeeding and rooming 
in with mothers has not been associated with any instance 
of Bilirubin Induced Neurological Dysfunction over the past 
4 years and before as well with the provision that babies at 
risk of hypoglycemia are assisted and given top up feeds 
when required inside NICU (this constitutes a negligible 
proportion of deliveries, and at discharge all babies are 
exclusively breastfed) (Sudevan P, personal communication). 
Furthermore, UDGP and other gene polymorphisms that 
potentiate pathological hyperbilirubinemia in breastfed 
infants have not been studied across all the population ethnic 
groups in India.
The 25 years of our battle against IMS (which are half won 
or half lost depending on how we perceive it) shall not lose 
its momentum at this critical juncture lest we fall back into 
the known traps of malnutrition and diarrheal deaths. Hence, 
exclusive breastfeeding shall continue to be our agenda with the 
rare exceptions for the situational use of substitutes, and even the 
later may be mitigated by the recent resurge in the process of 
establishing human milk banks.
CONCLUSIONS
This article provided the current evidence about the human versus 
formula milk and concluded that no significant advisory changes 
need to be incorporated in the existing policies on the promotion 
of breastfeeding. The exclusive breastfeeding shall continue to 
be our agenda, and the process of establishing human milk banks 
should be promoted to mitigate the rare situational use of milk 
substitutes.
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